In regards to cancer, recent studies have shown that focal deletion of PTPN2 was detected in human T-cell acute lymphoblastic leukemia, implying TC-PTP has the potential to act as a tumor suppressor11. The gene discussed is PTPN2; the disease is T-cell acute lymphoblastic leukemia.